heparin-EGF-like factor (Scios Nova)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameheparin-EGF-like factor (Scios Nova)
Drug Alias NameHB-EGF (Scios Nova)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionEpidermal growth factor receptor erbB1 agonists
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsRespiratory Tract DiseasesColitis, UlcerativeGastrointestinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesScios Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesScios Inc
Active IndicationsN/A
Inactive IndicationsRespiratory Tract DiseasesColitis, UlcerativeGastrointestinal Diseases

Other Information

ATC CodeN/A
Related LinksN/A